Health Outcomes in Acromegaly: Depression and Anxiety are Promising Targets for Improving Reduced Quality of Life.

Geraedts, Victor Jacobus; Dimopoulou, Christina; Auer, Matthias; Schopohl, Jochen; Stalla, Günter Karl; Sievers, Caroline

Geraedts, Victor Jacobus; Dimopoulou, Christina; Auer, Matthias; Schopohl, Jochen; Stalla, Günter Karl; Sievers, Caroline.

Afiliación

Geraedts VJ; Max Planck Institute of Psychiatry , Munich , Germany ; Leiden University Medical Center , Leiden , Netherlands.
Dimopoulou C; Max Planck Institute of Psychiatry , Munich , Germany.
Auer M; Max Planck Institute of Psychiatry , Munich , Germany.
Schopohl J; Medizinische Klinik Innenstadt, Ludwig-Maximilians University , Munich , Germany.
Stalla GK; Max Planck Institute of Psychiatry , Munich , Germany.
Sievers C; Max Planck Institute of Psychiatry , Munich , Germany.

Front Endocrinol (Lausanne) ; 5: 229, 2014.

Article en En | MEDLINE | ID: mdl-25610427

Palabras clave

acromegaly; anxiety; biochemical control; depression; pituitary adenomas; quality of life

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google